Home›Companies›Healthcare›SweetBio

SweetBio, Inc.

Updated Oct 27, 2026·Latest SEC filing Apr 30, 2024·Suggest an edit

About SweetBio

SweetBio is a private company based in Memphis, Tennessee. It has reported $4,594,031 raised in eight offerings on Form D since May 2015. Its chief executive is Kayla Graff.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetApr 30, 2024$0of $1.5M target0—Debt, OptionsRule 506(b)Form D ↗
Not yetNov 13, 2023$0of $6.0M target0—EquityRule 506(b)Form D ↗
Not yetJan 5, 2023$0of $1.0M target0—Debt, OptionsRule 506(b)Form D ↗
Not yetApr 22, 2022$0of $500K target0—Debt, OptionsRule 506(b)Form D ↗
Oct 1, 2020Oct 29, 2020$590,000of $1.5M target13$45,385Debt, Options, Convertible NoteRule 506(b)Form D ↗
Aug 30, 2019Sep 11, 2019$803,600of $810K target11$73,055Debt, Options, Convertible NoteRule 506(b)Form D ↗
Oct 31, 2018Nov 13, 2018$3,100,431of $3.2M target19$163KEquityRule 506(b)Form D ↗
May 11, 2015May 26, 2015$100,000fully sold3$33,333OptionsRule 506(b)Form D ↗
Total, eight offerings$4,594,031

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on SweetBio's Form D filed Apr 30, 2024.

KG
Kayla Graff
Chief Executive Officer & Secretary, director
IR
Isaac Rodriguez
Chief Science Officer & President, director
KG
Kevin Graff
Treasurer and director

Earlier filings also listed Jan Bouten (director, last listed Nov 2023), Marsalas Whitaker (executive officer and director, last listed May 2015) and Kayla Rodriguez (executive officer and director, last listed May 2015).

Sources

  1. SECSweetBio, Inc. filing history